Walsh Angela
SEC insider (Form 3/4/5 filer). CIK 0001825987. Chief Financial Officer at Dogwood Therapeutics, Inc. (DWTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 5, 2026. Located in ALPHARETTA, GA.
Companies Walsh Angela has filed insider reports for
- Dogwood Therapeutics, Inc. (DWTX): Officer, Chief Financial Officer
Walsh Angela
CIK: 0001825987
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DWTX
Dogwood Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 5, 2026DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
82.5K shares- - Dec 4, 2025DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
150K shares- - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
12.1K shares-
1-3 of 3 transactions